Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 21:12:129-139.
doi: 10.2147/CEG.S168266. eCollection 2019.

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management

Gabriele Capurso  1 , Mariaemilia Traini  1 , Matteo Piciucchi  2 , Marianna Signoretti  2 , Paolo Giorgio Arcidiacono  1
Affiliations
Review

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management

Gabriele Capurso et al. Clin Exp Gastroenterol. .

Abstract

Exocrine pancreatic insufficiency (EPI) is a condition caused by reduced or inappropriate secretion or activity of pancreatic juice and its digestive enzymes, pancreatic lipase in particular. EPI can result in clinical manifestation and biochemical alterations causing reduced quality of life and life-threating complications. EPI is common in pancreatic disorders, where it should be suspected and actively investigated, and in many extrapancreatic conditions. There are various tests available to diagnose EPI, with indirect, noninvasive ones, such as concentration of fecal elastase being more commonly employed. Administration of pancreatic enzymes replacement therapy remains the mainstay of EPI treatment. The present review article will discuss current evidence regarding the prevalence of EPI, the available tests to diagnose it and its treatment.

Keywords: chronic pancreatitis; diagnosis; elastase; exocrine pancreatic insufficiency; malnutrition; pancreatic cancer; therapy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) United European Gastroenterol J. 2017;5(2):153–199. - PMC - PubMed
    1. Forsmark CE. Diagnosis and management of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2018;16(3):306–315. - PubMed
    1. Johnson CD, Arbuckle R, Bonner N, et al. Qualitative assessment of the symptoms and impact of pancreatic exocrine insufficiency (PEI) to inform the development of a patient-reported outcome (pro) instrument. Patient. 2017;10(5):615–628. - PMC - PubMed
    1. Stigliano S, Waldthaler A, Martinez-Moneo E, et al. Vitamins D and K as factors associated with osteopathy in chronic pancreatitis: a prospective multicentre study (P-BONE study) Clin Transl Gastroenterol. 2018;9(10):197. - PMC - PubMed
    1. de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, López-López A, Nieto L, Domínguez-Muñoz JE. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J Clin Gastroenterol. 2018;52(8):e63–e72. - PubMed